Gene interactions and pathways from curated databases and text-mining

◀ Back to JUN

JUN — NFKBIA

Pathways - manually collected, often from reviews:

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Takata et al., Br J Pharmacol 2001 : 5. Pravastatin inhibit the activator protein-1 activity, but did not inhibit the activation of IkappaB-alpha
Zingarelli et al., FASEB J 2002 (Myocardial Infarction...) : These events were preceded by degradation of inhibitor kappaBalpha ( IkappaBalpha ), activation of IkappaB kinase complex (IKK) and c-Jun-NH2-terminal kinase (JNK), and subsequently activation of nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1) as early as 15 min after reperfusion ... These events were preceded by degradation of inhibitor kappaBalpha ( IkappaBalpha ), activation of IkappaB kinase complex (IKK) and c-Jun-NH2-terminal kinase (JNK) , and subsequently activation of nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1) as early as 15 min after reperfusion
Zingarelli et al., J Immunol 2003 (Bacteremia...) : These events were preceded by degradation of inhibitor kappaBalpha ( IkappaBalpha ), activation of IkappaB kinase complex , and c-Jun NH ( 2 ) -terminal kinase and, subsequently, activation of NF-kappaB and AP-1 in the lung
Krappmann et al., Mol Cell Biol 2004 : The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide induced gene expression and control subordinate activation of AP-1
Aneja et al., Mol Med 2004 (Myocardial Reperfusion Injury) : These events were associated with cytosol degradation of inhibitor kappaB-alpha, activation of IkappaB kinase , phosphorylation of c-Jun, and subsequent activation of nuclear factor-kappaB and activator protein-1 in the infarcted heart
Greenberg et al., Alcohol 1998 : ETOH does not directly inhibit NFkappaB or AP-1 , in vivo, but rather inhibits LPS induced activation of the MEKK/MAP kinase system and inhibition of inhibitory protein IkappaBalpha required for formation of AP-1 and NFkappaB, respectively